April 28, 2021
Baylor College of Medicine and Gensetix Inc. have agreed to end their patent dispute over a cancer therapy, according to a recent filing.
February 22, 2019
A Texas federal judge has rejected Baylor College of Medicine and its research partner's request to declare a cancer therapy patent infringement case exceptional so they could be awarded attorneys' fees as the self-declared prevailing party.
December 13, 2018
The University of Texas can't be forced to sue the Baylor College of Medicine for infringement of cancer therapy patents, and a drugmaker licensing those patents can't sue without UT by its side, a Texas federal judge has ruled, dooming the litigation.